Sign up now!
Don't show this again
Download the report!Continue to Site >
or wait 7 secs

Thank you for confirming your subscription!

(And remember, if ever you want to change your email preferences or unsubscribe, just click on the links at the bottom of any email.)

We’re glad you’re enjoying Pig Health Today.
Access is free but you’ll need to register to view more content.
Already registered? Sign In
Tap to download the app


Collect articles and features into your own report to read later, print or share with others

Create a New Report


Read Later

Create a new report

Report title (required) Brief description (optional)
follow us

You must be logged in to edit your profile.

Favorites Read Later My Reports PHT Special Reports
Pig Health Today is equipped with some amazing (and free) tools for organizing and sharing content, as well as creating your own magazines and special reports. To access them, please register today.
Sponsored by Zoetis

Pig Health Today | Sponsored by Zoetis


Currently available vaccines important tools for managing PEDV-infected sow herds

Currently available vaccines can be important tools for managing sow herds endemically infected with porcine epidemic diarrhea virus (PEDV), indicates a study presented at the 2017 annual meeting of the American Association of Swine Veterinarians.1

Monitoring and maintaining levels of immunity sufficient to protect neonatal pigs is needed because there’s little possibility PEDV will be eradicated anytime soon, said Jordan Kraft, a veterinary student at Iowa State University.

Kraft and colleagues conducted a study to compare gilt responses to vaccination using two commercially available PEDV vaccines. Gilt immune response was measured by immunoglobulin levels, specifically IgA and IGg, and neutralizing antibody levels in serum, colostrum and milk samples.

PEDV antibody-positive commercial gilts were randomly assigned to one of five groups. One group received the commercial “Vaccine A” at 2 weeks pre-farrowing, and another group received the vaccine at 5 and 2 weeks pre-farrowing. The other commercial PEDV vaccine, “Vaccine B,” was also administered at 2 weeks pre-farrowing or at 5 and 2 weeks pre-farrowing. The fifth group received no vaccine and served as a control.

The investigators found that in gilts with prior exposure to PEDV, vaccination significantly (p < 0.05) increased IgG, IgA and neutralizing antibody levels based on samples of serum, colostrum and milk taken after farrowing. Gilts that received Vaccine B, a conditionally licensed Zoetis product, had higher IgG levels in serum and colostrum compared to the results with Vaccine A, Kraft reported.

Gilt serum antibody levels taken at 5 weeks pre-farrowing — before vaccination and measured as IgG and IgA by the fluorescent focus neutralization assay — were similar among the groups, which provides evidence that the differences found were due to vaccination, Kraft said.




1 Kraft J, et al. Serum and mammary secretion antibody responses in PEDV-exposed gilts following PEDV vaccination. In: Proceedings of the 48th Annual Meeting of the American Association of Swine Veterinarians (February 25-28, 2017). Page 50.





Posted on August 18, 2017

tags: , ,

You must be logged in to edit your profile.

Share It
US producers and veterinarians have seen an influx of different types of influenza viruses in the last 10 to 15 years, and that is a major reason why influenza is more difficult to control.

Click an icon to share this information with your industry contacts.
Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.